Black Women Report Positive Experience With Long-Acting Injectable PrEP
Black women who received long-acting cabotegravir for pre-exposure prophylaxis (PrEP) found it to be feasible and easily accessible, having an overall positive experience, according...
Lenacapavir Shows No Effect on Gender-Affirming Hormone Levels in Diverse PrEP Trial
Lenacapavir pre-exposure prophylaxis (PrEP) can safely be given to transgender and gender-diverse persons who are receiving gender-affirming hormone therapy (GAHT), according to recent study...
Gaps in Communication Lead to Missed Care, Late-Stage HIV Diagnoses
Despite having previous interactions with the health care system, more than half of patients in a recent study received a late-stage HIV diagnosis.
The prospective,...
How Zoster Vaccination Status in People With HIV Affects Risk of Death, Cardiovascular Events
People living with HIV who have had prior zoster vaccination have a significantly reduced risk of all-cause mortality and major adverse cardiovascular events (MACE),...